Literature DB >> 24361416

Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis.

Eran Israeli1, Lesley A Graff2, Ian Clara3, John R Walker2, Lisa M Lix3, Laura E Targownik4, Charles N Bernstein4.   

Abstract

BACKGROUND & AIMS: Disability is defined by chronic limitations that preclude the ability to engage in usual daily activities. Studies of disability in patients with inflammatory bowel disease (IBD) have focused on work and employment, with few descriptions of more general disability among multiple domains. We examined disability and the factors associated with it a decade after diagnosis in a population-based cohort of IBD patients.
METHODS: We interviewed 125 patients with Crohn's disease (CD) and 119 with ulcerative colitis (UC) from the population-based Manitoba IBD Cohort study a median of 12.3 years after diagnosis. Disability was assessed by using 2 validated measures. Disease activity was assessed semiannually, and long-term activity was defined as symptoms of active IBD at more than 65% of semiannual assessments.
RESULTS: Mean levels of disability were significantly higher among patients with CD than those with UC (P < .01). On the basis of the Work and Social Adjustment Scale, rates of disability were 19% among patients with CD vs 11% among those with UC (P < .05). Results from the World Health Organization Disability Assessment Schedule v.2 and the Work and Social Adjustment Scale correlated (r = 0.58 for patients with CD and 0.60 for those with UC; P < .01). Disability was associated with reduced quality of life. Long-term active disease and a lifetime history of major depression were associated with disability, whereas history of IBD-related surgeries or hospitalizations was not.
CONCLUSIONS: A minority of patients with IBD have significant disability after a decade of disease, although a higher proportion of patients with CD are disabled than those with UC. Long-term active disease and psychological factors are important predictors of disability. Depression should be treated as aggressively as the IBD itself.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disability; IBD; QoL; WHODAS2

Mesh:

Year:  2013        PMID: 24361416     DOI: 10.1016/j.cgh.2013.12.009

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  11 in total

Review 1.  Impact of inflammatory bowel disease on disability.

Authors:  Katharina Büsch; Amnon Sonnenberg; Nick Bansback
Journal:  Curr Gastroenterol Rep       Date:  2014-10

2.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

3.  Examining Psychosocial Mechanisms of Pain-Related Disability in Inflammatory Bowel Disease.

Authors:  Katherine M Fretz; Dean A Tripp; Laura Katz; Mark Ropeleski; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2020-03

Review 4.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

5.  Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.

Authors:  Michael D Mandel; Mandel D Michael; Anita Bálint; Barbara D Lovász; László Gulácsi; Bálint Strbák; Petra A Golovics; Klaudia Farkas; Zsuzsanna Kürti; Blanka K Szilágyi; Anna Mohás; Tamás Molnár; Péter L Lakatos
Journal:  Eur J Health Econ       Date:  2014-05-16

6.  Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics.

Authors:  Konstantinos Argyriou; Andreas Kapsoritakis; Konstantinos Oikonomou; Anastassios Manolakis; Eirini Tsakiridou; Spyridon Potamianos
Journal:  Can J Gastroenterol Hepatol       Date:  2017-05-29

7.  Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life.

Authors:  Jin Young Yoon; Jeong Eun Shin; Sang Hyoung Park; Dong Il Park; Jae Myung Cha
Journal:  Gut Liver       Date:  2017-05-15       Impact factor: 4.519

8.  The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.

Authors:  Murray W Enns; Charles N Bernstein; Kristine Kroeker; Lesley Graff; John R Walker; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; John D Fisk; Ruth Ann Marrie
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

9.  The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Authors:  Jennifer L Jones; Geoffrey C Nguyen; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Gilaad G Kaplan; Sanjay K Murthy; Kate Lee; Jane Cooke-Lauder; Anthony R Otley
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

10.  Evaluating Disability in Inflammatory Bowel Diseases: A Step Forward for Improved Care.

Authors:  Joana Torres
Journal:  GE Port J Gastroenterol       Date:  2015-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.